Josimovic-Alasevic O, Herrmann T, Diamantstein T
Institut für Immunologie, Freie Universität Berlin, FRG.
Eur J Immunol. 1988 Nov;18(11):1855-7. doi: 10.1002/eji.1830181133.
The release of interleukin 2 (IL2)-binding proteins, derived from the 55-kDa low-affinity IL2 receptor (IL2R; L chain), has been observed for virtually all L chain-bearing cells in either humans, the mouse or the rat. Based on the characterization of the released human L chain as a molecule 10 kDa smaller than the cell surface receptor, either proteolytic cleavage or differential splicing of the L chain-encoding mRNA have been suggested as mechanisms underlying the receptor release. Combining affinity labeling of the L chain with 125I-labeled IL2 and immunoprecipitation with L chain-specific monoclonal antibodies applied for the detection of soluble mouse IL2R revealed the existence of two classes of soluble receptors, one being of the same size as cell surface expressed L chain, the other of 45-kDa apparent molecular mass. These findings raise the possibility of mechanisms of receptor release other than those discussed for human L chain.
几乎在人类、小鼠或大鼠的所有携带低亲和力白细胞介素2受体(IL2R;轻链)的55 kDa轻链细胞中,都观察到了源自该轻链的白细胞介素2(IL2)结合蛋白的释放。基于所释放的人类轻链被表征为比细胞表面受体小10 kDa的分子,有人提出蛋白水解切割或轻链编码mRNA的差异剪接是受体释放的潜在机制。将轻链与125I标记的IL2进行亲和标记,并应用轻链特异性单克隆抗体进行免疫沉淀以检测可溶性小鼠IL2R,结果显示存在两类可溶性受体,一类与细胞表面表达的轻链大小相同,另一类表观分子量为45 kDa。这些发现增加了存在不同于人类轻链所讨论的受体释放机制的可能性。